四川大通信宏医药集团有限公司

Chinese pharmaceutical group founded in 2009 and headquartered in Chengdu, Sichuan with 20 million yuan of registered capital, combining drug research, manufacturing and sales through subsidiaries in research, marketing authorisation holding, manufacturing and pharmaceutical trading. Runs formulation plants and active ingredient and excipient plants in Sichuan, Hebei and Shanxi with a sales centre and research centre in Chengdu equipped for full active ingredient and formulation development. Sells through thousands of regional agents and tens of thousands of hospital, pharmacy and third-terminal customers with branch offices across major Chinese cities, covering hospital prescription, medical device and consumable, over-the-counter and health food markets in infection, oncology, respiratory, central nervous system, ophthalmology, orthopaedics, dermatology, paediatrics and gynaecology.